Novartis said 20 commercial insurance plans and four Medicaid plans have policies in place on coverage of its gene therapy Zolgensma, the world's most expensive drug, according to BioPharma Dive.
Pharmacy
Bayer is recalling two lots, or about 990 vials, of its biologic drug that helps prevent and control hemorrhagic episodes in patients with hemophilia A.
Amazon is threatening to sue Surescripts, an electronic-prescribing company owned by companies including CVS and Express Scripts, to halt an attempt to limit PillPack's access to patient health data, according to CNBC.
Below are 10 commonly prescribed drugs that increased in list price in the second quarter of 2019, according to GoodRx's latest quarterly report.
Friends and family of a 21-year-old diabetic patient said Jesimya David Scherer-Radcliff died as a result of rationing insulin, according to Minnesota news station KARE 11.
Novartis is setting aside $700 million to settle allegations that it paid kickbacks to physicians to boost prescription rates of several medications, according to STAT.
Inovio Pharmaceuticals, a biotechnology company in Plymouth Meeting, Pa., has cut its workforce by 28 percent and axed several early-stage research and development programs to reduce annual expenses.
Pharmacists that work at general merchandise stores have the highest median salary per year, according to the U.S. Bureau of Labor Statistics.
Altaire Pharmaceuticals is expanding its recall of over-the-counter eye drops and ointments due to sterility concerns.
Below are the 10 most prescribed drugs during the three months ended June 30, according to GoodRx's latest quarterly report.